Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000053

Options or other derivatives

  • President and CEO acquired 1,951,703 shares (grant or award)
  • President and CEO returned 1,951,703 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Coulie Bernard President and CEO 2026-04-17 Returned to the company · Stock Option (Right to Buy) −146,841 0 D
Coulie Bernard President and CEO 2026-04-17 Grant or award · Stock Option (Right to Buy) +146,841 146,841 D
Coulie Bernard President and CEO 2026-04-17 Returned to the company · Stock Option (Right to Buy) −327,262 0 D
Coulie Bernard President and CEO 2026-04-17 Grant or award · Stock Option (Right to Buy) +327,262 327,262 D
Coulie Bernard President and CEO 2026-04-17 Returned to the company · Stock Option (Right to Buy) −250,000 0 D
Coulie Bernard President and CEO 2026-04-17 Grant or award · Stock Option (Right to Buy) +250,000 250,000 D
Coulie Bernard President and CEO 2026-04-17 Returned to the company · Stock Option (Right to Buy) −440,000 0 D
Coulie Bernard President and CEO 2026-04-17 Grant or award · Stock Option (Right to Buy) +440,000 440,000 D
Coulie Bernard President and CEO 2026-04-17 Returned to the company · Stock Option (Right to Buy) −206,300 0 D
Coulie Bernard President and CEO 2026-04-17 Grant or award · Stock Option (Right to Buy) +206,300 206,300 D
Coulie Bernard President and CEO 2026-04-17 Returned to the company · Stock Option (Right to Buy) −256,300 0 D
Coulie Bernard President and CEO 2026-04-17 Grant or award · Stock Option (Right to Buy) +256,300 256,300 D
Coulie Bernard President and CEO 2026-04-17 Returned to the company · Stock Option (Right to Buy) −325,000 0 D
Coulie Bernard President and CEO 2026-04-17 Grant or award · Stock Option (Right to Buy) +325,000 325,000 D
Loading xslF345X06/wk-form4_1776458555.xml…